$VNDA
Vanda Pharmaceuticals Inc.

2014 Q1 Form 10-K Financial Statement

#000119312514066051 Filed on February 25, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q4 2013 Q3
Revenue $9.143M $8.783M $8.709M
YoY Change 13.32% 10.9% 5.08%
Cost Of Revenue
YoY Change
Gross Profit $9.143M
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin $27.89M $9.930M $5.741M
YoY Change 571.63% 207.43% 82.25%
% of Gross Profit 305.07%
Research & Development $7.263M $6.270M $8.022M
YoY Change -10.45% -40.96% -21.04%
% of Gross Profit 79.44%
Depreciation & Amortization $125.0K $500.0K $500.0K
YoY Change 16.82% 0.0% 0.0%
% of Gross Profit 1.37%
Operating Expenses $35.16M $16.57M $13.76M
YoY Change 186.66% 16.53% 35.48%
Operating Profit -$26.58M -$7.791M -$5.431M
YoY Change 482.21% 21.2% 0.67%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $50.00K $40.00K $30.00K
YoY Change 0.0% -33.33% -57.14%
Pretax Income -$26.53M -$7.750M -$5.380M
YoY Change 487.14% 21.66% 1.01%
Income Tax
% Of Pretax Income
Net Earnings -$26.53M -$7.747M -$5.406M
YoY Change 487.14% 21.64% 1.5%
Net Earnings / Revenue -290.2% -88.2% -62.07%
Basic Earnings Per Share -$0.79 -$0.23 -$0.17
Diluted Earnings Per Share -$0.79 -$0.23 -$0.17
COMMON SHARES
Basic Shares Outstanding 33.50M shares 33.19M shares 31.33M shares
Diluted Shares Outstanding 31.33M shares

Balance Sheet

Concept 2014 Q1 2013 Q4 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $100.4M $130.4M $142.2M
YoY Change -9.49% 8.26% 5.8%
Cash & Equivalents $43.26M $64.76M $142.2M
Short-Term Investments $57.14M $65.59M $0.00
Other Short-Term Assets $3.200M $128.0K $2.900M
YoY Change -13.51% -97.09% -23.68%
Inventory $192.0K $0.00 $0.00
Prepaid Expenses
Receivables $1.691M $2.031M $1.956M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $105.5M $135.6M $147.1M
YoY Change -9.12% 7.66% 5.13%
LONG-TERM ASSETS
Property, Plant & Equipment $2.208M $2.198M $2.106M
YoY Change -2.47% -6.39% -12.25%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $800.0K $500.0K $500.0K
YoY Change 33.33% -16.67% -16.67%
Total Long-Term Assets $15.47M $7.735M $8.020M
YoY Change 71.32% -18.41% -18.99%
TOTAL ASSETS
Total Short-Term Assets $105.5M $135.6M $147.1M
Total Long-Term Assets $15.47M $7.735M $8.020M
Total Assets $121.0M $143.3M $155.1M
YoY Change -3.32% 5.83% 3.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $953.0K $661.0K $369.0K
YoY Change -14.38% 130.31% -66.45%
Accrued Expenses $13.16M $5.180M $4.532M
YoY Change 239.8% -0.13% -33.35%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $45.40M $32.85M $31.91M
YoY Change 42.01% 1.82% -7.79%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $54.60M $66.40M $73.20M
YoY Change -37.02% -28.83% -26.65%
Total Long-Term Liabilities $54.60M $66.40M $73.20M
YoY Change -37.02% -28.83% -26.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $45.40M $32.85M $31.91M
Total Long-Term Liabilities $54.60M $66.40M $73.20M
Total Liabilities $100.0M $99.23M $105.1M
YoY Change -15.73% -20.96% -21.87%
SHAREHOLDERS EQUITY
Retained Earnings -$334.7M -$308.2M -$303.7M
YoY Change 13.35% 5.86%
Common Stock $355.7M $352.3M $353.7M
YoY Change 17.87% 17.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $20.98M $44.12M $50.00M
YoY Change
Total Liabilities & Shareholders Equity $121.0M $143.3M $155.1M
YoY Change -3.32% 5.83% 3.53%

Cashflow Statement

Concept 2014 Q1 2013 Q4 2013 Q3
OPERATING ACTIVITIES
Net Income -$26.53M -$7.747M -$5.406M
YoY Change 487.14% 21.64% 1.5%
Depreciation, Depletion And Amortization $125.0K $500.0K $500.0K
YoY Change 16.82% 0.0% 0.0%
Cash From Operating Activities -$23.90M -$12.20M -$10.20M
YoY Change 161.96% -11.59% 0.0%
INVESTING ACTIVITIES
Capital Expenditures $135.0K -$100.0K $0.00
YoY Change 486.96%
Acquisitions
YoY Change
Other Investing Activities $8.500M -$65.60M $0.00
YoY Change -72.13% 3352.63% -100.0%
Cash From Investing Activities $389.0K -$65.70M $0.00
YoY Change -98.72% 3357.89% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $48.50M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.011M 500.0K 48.80M
YoY Change -1141.97%
NET CHANGE
Cash From Operating Activities -23.90M -12.20M -10.20M
Cash From Investing Activities 389.0K -65.70M 0.000
Cash From Financing Activities 2.011M 500.0K 48.80M
Net Change In Cash -21.50M -77.40M 38.60M
YoY Change -201.63% 392.99% 282.18%
FREE CASH FLOW
Cash From Operating Activities -$23.90M -$12.20M -$10.20M
Capital Expenditures $135.0K -$100.0K $0.00
Free Cash Flow -$24.04M -$12.10M -$10.20M
YoY Change 162.78% -12.32% 0.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33501902 shares
CY2013Q2 dei Entity Public Float
EntityPublicFloat
194000000
CY2009Q4 vnda Non Refundable Research And Development License Payments Received
NonRefundableResearchAndDevelopmentLicensePaymentsReceived
200000000
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
37731000
CY2010Q4 us-gaap Deferred Revenue
DeferredRevenue
170642000
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42559000
CY2011Q4 us-gaap Restructuring Reserve
RestructuringReserve
740000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
33474000
CY2011Q4 us-gaap Deferred Revenue
DeferredRevenue
143853000
CY2011Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
430000
CY2011Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
600000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87923000
CY2011Q4 vnda Leased Square Footage
LeasedSquareFootage
21400 sqft
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28241743 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28241743 shares
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
90275000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
32263000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
127000
CY2012Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
4000
CY2012Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
2273000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
818000
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
321000
CY2012Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2277000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
287000
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
386000
CY2012Q4 us-gaap Restructuring Reserve
RestructuringReserve
453000
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
133272000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
9905000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
300974000
CY2012Q4 us-gaap Deferred Revenue
DeferredRevenue
117064000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-291107000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
26789000
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5187000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
10000
CY2012Q4 us-gaap Liabilities
Liabilities
125543000
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5468000
CY2012Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
3005000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
28000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
135448000
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
430000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
17348000
CY2012Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
31631000
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
135549000
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
600000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
522000
CY2012Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
3536000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1168000
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3166000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2348000
CY2012Q4 us-gaap Assets
Assets
135448000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88772000
CY2012Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
276000
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6532000
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
38840000
CY2012Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
47509000
CY2012Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
31631000
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12000000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3967000
CY2012Q4 us-gaap Prepaid Insurance
PrepaidInsurance
155000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
125968000
CY2012Q4 vnda Deferred Tax Assets Liabilities Before Valuation Allowance Net
DeferredTaxAssetsLiabilitiesBeforeValuationAllowanceNet
133272000
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 vnda Deferred Tax Asset Depreciation And Amortization
DeferredTaxAssetDepreciationAndAmortization
28000
CY2012Q4 vnda Accrued Research And Development Expense
AccruedResearchAndDevelopmentExpense
3900000
CY2012Q4 vnda Deferred Tax Assets Tax Credit Carryforwards Research And Other
DeferredTaxAssetsTaxCreditCarryforwardsResearchAndOther
31302000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33338543 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
11.14
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33338543 shares
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
63486000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1111000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
32851000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
5159000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
176000
CY2013Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
9000
CY2013Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
616000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1249000
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
606000
CY2013Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
625000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
10750000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
661000
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2015000
CY2013Q4 us-gaap Restructuring Reserve
RestructuringReserve
59000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1133000
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
141150000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
44124000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
355432000
CY2013Q4 us-gaap Deferred Revenue
DeferredRevenue
90275000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-311362000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
26789000
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5180000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1079000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
21000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1162000
CY2013Q4 us-gaap Liabilities
Liabilities
99225000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1106000
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6963000
CY2013Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2888000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
33000
CY2013Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
221000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
143349000
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
530000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1495000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
17626000
CY2013Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
65586000
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
141775000
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
500000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
566000
CY2013Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2408000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2031000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1495000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3447000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
552000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2198000
CY2013Q4 us-gaap Assets
Assets
143349000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64764000
CY2013Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
128000
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5037000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1495000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
48206000
CY2013Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
36670000
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
65586000
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12000000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2703000
CY2013Q4 us-gaap Prepaid Insurance
PrepaidInsurance
167000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
135614000
CY2013Q4 vnda Deferred Tax Assets Liabilities Before Valuation Allowance Net
DeferredTaxAssetsLiabilitiesBeforeValuationAllowanceNet
141150000
CY2013Q4 vnda Deferred Tax Asset Depreciation And Amortization
DeferredTaxAssetDepreciationAndAmortization
110000
CY2013Q4 vnda Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
2 EquityPlan
CY2013Q4 vnda Accrued Research And Development Expense
AccruedResearchAndDevelopmentExpense
2324000
CY2013Q4 vnda Liabilities Recorded Future License Payments
LiabilitiesRecordedFutureLicensePayments
0
CY2013Q4 vnda Liabilities Recorded Contractual Obligations Relating To License Agreements
LiabilitiesRecordedContractualObligationsRelatingToLicenseAgreements
0
CY2013Q4 vnda Deferred Tax Assets Tax Credit Carryforwards Research And Other
DeferredTaxAssetsTaxCreditCarryforwardsResearchAndOther
38597000
CY2013Q3 vnda Upfront License Fee And Milestone Payments Made
UpfrontLicenseFeeAndMilestonePaymentsMade
3000000
CY2009Q2 vnda Milestone Payment Made Under License Agreement
MilestonePaymentMadeUnderLicenseAgreement
12000000
CY2011 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.009 pure
CY2011 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0145 pure
CY2011 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
CY2011 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28106831 shares
CY2011 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.340 pure
CY2011 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
CY2011 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.046 pure
CY2011 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.043 pure
CY2011 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y11D
CY2011 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
1.011 pure
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.50
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28410000
CY2011 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.053 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.002 pure
CY2011 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4559432 shares
CY2011 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28106831 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.71 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
-0.604 pure
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
275000
CY2011 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
600000
CY2011 us-gaap Licenses Revenue
LicensesRevenue
26789000
CY2011 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
160213000
CY2011 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
19000
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10246000
CY2011 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-900000
CY2011 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
10300000
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1107000
CY2011 us-gaap Other Income
OtherIncome
461000
CY2011 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
25000
CY2011 us-gaap Revenues
Revenues
31270000
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1240000
CY2011 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9783000
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-10707000
CY2011 us-gaap Royalty Revenue
RoyaltyRevenue
4481000
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-9802000
CY2011 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
-700000
CY2011 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
19000
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5501000
CY2011 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1821000
CY2011 us-gaap Costs And Expenses
CostsAndExpenses
41977000
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11486000
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25000
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
5501000
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
45364000
CY2011 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-1151000
CY2011 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
8667000
CY2011 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
25000
CY2011 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-1114000
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-444000
CY2011 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-26789000
CY2011 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1836000
CY2011 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-2266000
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
348000
CY2011 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1821000
CY2011 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
424000
CY2011 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2011 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
469000
CY2011 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
CY2011 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1495000
CY2011 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
226170000
CY2011 us-gaap Restructuring Charges
RestructuringCharges
-740000
CY2011 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5486000
CY2011 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
26789000
CY2011 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2100000
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
73749000
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28996000
CY2011 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
221000
CY2011 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000
CY2011 vnda Deductible Expenses Resulting From Change In Tax Accounting Method
DeductibleExpensesResultingFromChangeInTaxAccountingMethod
53800000
CY2013 dei Trading Symbol
TradingSymbol
VNDA
CY2013 dei Entity Registrant Name
EntityRegistrantName
Vanda Pharmaceuticals Inc.
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0001347178
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.015 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.003 pure
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0159 pure
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30351353 shares
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.340 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.012 pure
CY2013 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.011 pure
CY2013 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P8Y
CY2013 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4680000 shares
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y11D
CY2013 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
49520 shares
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.439 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.10
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39592000
CY2013 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Concentrations of credit risk</i></b></font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Financial instruments which potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents and marketable securities. The Company places its cash, cash equivalents and marketable securities with highly-rated financial institutions. At December&#xA0;31, 2013, the Company maintained all of its cash, cash equivalents and marketable securities in two financial institutions. Deposits held with these institutions may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand, and the Company believes there is minimal risk of losses on such balances.</font></p> </div>
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.040 pure
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 6px"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Use of estimates</i></b></font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates that affect the reported amounts of assets and liabilities at the date of the financial statements, disclosure of contingent assets and liabilities, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</font></p> </div>
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4444912 shares
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30351353 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.65 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
-0.227 pure
CY2013 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
CY2013 us-gaap Payments For Restructuring
PaymentsForRestructuring
384000
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
48505000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
176000
CY2013 us-gaap Licenses Revenue
LicensesRevenue
26789000
CY2013 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
65598000
CY2013 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
11000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20255000
CY2013 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-155000
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
7900000
CY2013 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
196000
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
863000
CY2013 us-gaap Other Income
OtherIncome
145000
CY2013 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1550000
CY2013 us-gaap Revenues
Revenues
33879000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1264000
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20244000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-20400000
CY2013 us-gaap Royalty Revenue
RoyaltyRevenue
7090000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-20255000
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
11000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4604000
CY2013 us-gaap Costs And Expenses
CostsAndExpenses
54279000
CY2013 vnda Defined Contribution Plan Employer Contribution Maximum Match Percent
DefinedContributionPlanEmployerContributionMaximumMatchPercent
0.50 pure
CY2013 vnda Defined Contribution Plan Employee Contribution Threshold For Matching Calculation
DefinedContributionPlanEmployeeContributionThresholdForMatchingCalculation
0.06 pure
CY2004 vnda Upfront License Fee And Milestone Payments Made
UpfrontLicenseFeeAndMilestonePaymentsMade
500000
CY2004 vnda Future Percentage Of Royalty Payments Based On Net Sales
FuturePercentageOfRoyaltyPaymentsBasedOnNetSales
Low teens
CY2004 vnda Percentage Of Future Sublicense Fees Payable
PercentageOfFutureSublicenseFeesPayable
Mid-twenties
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24594000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49859000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
4604000
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1495000
CY2013 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
31499000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-24008000
CY2013 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
196000
CY2013 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
1550000
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-26789000
CY2013 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-113000
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
374000
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
48505000
CY2013 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
104000
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
432000
CY2013 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
CY2013 us-gaap Restructuring Charges
RestructuringCharges
10000
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4477000
CY2013 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
26789000
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1100000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-34275000
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28190000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
1300000
CY2013 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
106000
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
200000
CY2013 vnda Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Share Subject To Option Awards
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfShareSubjectToOptionAwards
0.25 pure
CY2013 vnda Share Based Compensation Arrangement By Share Based Payment Award Remaining Percentage Of Share Subject To Option Awards
ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingPercentageOfShareSubjectToOptionAwards
0.75 pure
CY2013 vnda Defined Contribution Plan Vesting Period
DefinedContributionPlanVestingPeriod
P4Y
CY2013 vnda Initial Stock Options Granted To Directors Vesting And Exercisable Period
InitialStockOptionsGrantedToDirectorsVestingAndExercisablePeriod
P4Y
CY2013 vnda Sharebased Compensation Arrangement By Sharebased Payment Award Restricted Stock Units Or Non Vested Shares Vesting Period1
SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockUnitsOrNonVestedSharesVestingPeriod1
P4Y
CY2013 vnda Potential Pediatric Extension
PotentialPediatricExtension
P6M
CY2013 vnda Tax Credit Carryforward Beginning Expiration Year
TaxCreditCarryforwardBeginningExpirationYear
2024
CY2013 vnda Subsequent Stock Options Granted To Directors Vesting And Exercisable Period
SubsequentStockOptionsGrantedToDirectorsVestingAndExercisablePeriod
P1Y
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.070 pure
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.98
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0094 pure
CY2013 vnda Operating Loss Carryforwards Beginning Expiration Year
OperatingLossCarryforwardsBeginningExpirationYear
2028
CY2013 vnda Patent Extension Received Under Hatch Waxman Extension
PatentExtensionReceivedUnderHatchWaxmanExtension
P5Y
CY2013 vnda Share Based Compensation Option Awards Contractual Term
ShareBasedCompensationOptionAwardsContractualTerm
P10Y
CY2013 vnda Option Awards Vesting Period After Completion Of One Year Of Service
OptionAwardsVestingPeriodAfterCompletionOfOneYearOfService
P3Y
CY2004 vnda Possible Future Milestone Payment Based On Sales Event
PossibleFutureMilestonePaymentBasedOnSalesEvent
25000000
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.021 pure
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.98
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28228409 shares
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.340 pure
CY2012 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
CY2012 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.008 pure
CY2012 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P8Y
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y11D
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.703 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.08
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-44917000
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.033 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.014 pure
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5219183 shares
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28228409 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.68 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
-0.303 pure
CY2012 us-gaap Payments For Restructuring
PaymentsForRestructuring
1507000
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2017000
CY2012 us-gaap Licenses Revenue
LicensesRevenue
26789000
CY2012 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
60866000
CY2012 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-11000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27664000
CY2012 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-560000
CY2012 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
19400000
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-450000
CY2012 us-gaap Other Income
OtherIncome
561000
CY2012 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12000
CY2012 us-gaap Revenues
Revenues
32727000
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
884000
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27675000
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-28225000
CY2012 us-gaap Royalty Revenue
RoyaltyRevenue
5938000
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-27664000
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4094000
CY2012 us-gaap Cost Of Goods Sold
CostOfGoodsSold
129000
CY2012 us-gaap Costs And Expenses
CostsAndExpenses
60952000
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13882000
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12000
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
4094000
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
849000
CY2012 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
2497000
CY2012 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
12000
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-26789000
CY2012 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1806000
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-709000
CY2012 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
265000
CY2012 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
633000
CY2012 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
CY2012 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1495000
CY2012 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
106140000
CY2012 us-gaap Restructuring Charges
RestructuringCharges
-1220000
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4074000
CY2012 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
26789000
CY2012 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2000000
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
45754000
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45446000
CY2012 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000
CY2012 vnda Allowance For Tenant Improvements
AllowanceForTenantImprovements
1900000
CY2012 vnda Landlord Contributions For Tenant Improvements
LandlordContributionsForTenantImprovements
1826000
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2013Q1 us-gaap Revenues
Revenues
8068000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4219000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-4173000
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2012Q1 us-gaap Revenues
Revenues
8141000
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8317000
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-7962000
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2012Q2 us-gaap Revenues
Revenues
8378000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8085000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-8007000
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2013Q2 us-gaap Revenues
Revenues
8319000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3109000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-3079000
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2012Q3 us-gaap Revenues
Revenues
8288000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5395000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-5326000
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2013Q3 us-gaap Revenues
Revenues
8709000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5405000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-5380000
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2012Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2012Q4 us-gaap Revenues
Revenues
7920000
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-6428000
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-6369000
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2013Q4 us-gaap Revenues
Revenues
8783000
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-7667000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-7623000

Files In Submission

Name View Source Status
0001193125-14-066051-index-headers.html Edgar Link pending
0001193125-14-066051-index.html Edgar Link pending
0001193125-14-066051.txt Edgar Link pending
0001193125-14-066051-xbrl.zip Edgar Link pending
d638779d10k.htm Edgar Link pending
d638779dex1052.htm Edgar Link pending
d638779dex231.htm Edgar Link pending
d638779dex311.htm Edgar Link pending
d638779dex312.htm Edgar Link pending
d638779dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g638779g52s00.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vnda-20131231.xml Edgar Link completed
vnda-20131231.xsd Edgar Link pending
vnda-20131231_cal.xml Edgar Link unprocessable
vnda-20131231_def.xml Edgar Link unprocessable
vnda-20131231_lab.xml Edgar Link unprocessable
vnda-20131231_pre.xml Edgar Link unprocessable